×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| FDC LTD. | 4775.07 | 364.47 | 4588.62 | 2.24 | 6,572 | 24.0 |
| STRIDES PHARMA SCIENCE LIMITED | 5533.45 | 149.38 | 5509.17 | 1.62 | 6009 | 24.1 |
| Supriya Lifescience Limited | 1877.46 | 467.83 | 1856.48 | 5.82 | 5150 | 29.5 |
FDC Ltd., with Security Code 531599, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 446.2 | 406.6 | 431.1 | 530.0 | 479.6 | 452.2 | 454.2 | 624.1 | 505.1 | 458.8 |
| Expenses | 395.1 | 360.1 | 377.3 | 410.0 | 401.0 | 370.3 | 396.4 | 482.4 | 432.7 | 412.9 |
| Operating Profit | 51.1 | 46.5 | 53.9 | 120.0 | 78.7 | 81.9 | 57.8 | 141.7 | 72.4 | 45.9 |
| OPM % | 11.46% | 11.44% | 12.49% | 22.64% | 16.41% | 18.11% | 12.73% | 22.7% | 14.33% | 10.01% |
| Other Income | 28.6 | 18.8 | 10.1 | 29.8 | 27.4 | 25.3 | 20.7 | 28.2 | 34.7 | 18.6 |
| Interest | 1.0 | 1.2 | 1.1 | 1.0 | 1.1 | 1.0 | 0.9 | 1.3 | 1.1 | 0.9 |
| Depreciation | 9.9 | 9.8 | 9.7 | 9.6 | 9.8 | 9.9 | 10.4 | 11.0 | 13.8 | 13.3 |
| Profit before tax | 68.8 | 54.3 | 53.2 | 139.2 | 95.2 | 96.3 | 67.2 | 157.6 | 92.3 | 50.3 |
| Tax % | 25.5% | 27.4% | 30% | 22% | 24.4% | 18.6% | 28.3% | 27% | 19.8% | 27.6% |
| Net Profit | 51.3 | 39.4 | 37.2 | 108.6 | 72.0 | 78.4 | 48.2 | 115.0 | 74.0 | 36.4 |
| EPS in Rs | 3.07 | 2.38 | 2.24 | 6.54 | 4.36 | 4.81 | 2.97 | 7.06 | 4.55 | 2.24 |
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 494.7 | 445.0 | 409.3 | 434.8 | 536.4 | 486.4 | 458.2 | 462.0 | 638.3 | 513.8 |
| Expenses | 416.7 | 377.7 | 360.1 | 385.9 | 414.4 | 409.9 | 374.4 | 405.7 | 491.7 | 443.7 |
| Operating Profit | 78.0 | 67.3 | 49.2 | 49.0 | 122.0 | 76.4 | 83.8 | 56.3 | 146.6 | 70.2 |
| OPM % | 15.8% | 15.1% | 12% | 11.3% | 22.7% | 15.7% | 18.3% | 12.2% | 23% | 13.7% |
| Other Income | 19.1 | 12.7 | 18.4 | 7.1 | 29.4 | 27.2 | 24.7 | 20.3 | 28.4 | 34.7 |
| Interest | 0.7 | 1.0 | 1.2 | 1.2 | 1.0 | 1.1 | 1.0 | 1.0 | 1.3 | 1.1 |
| Depreciation | 9.4 | 10.0 | 9.9 | 9.7 | 9.6 | 9.9 | 10.0 | 10.4 | 11.0 | 13.8 |
| Profit before tax | 87.0 | 69.1 | 56.6 | 45.1 | 140.7 | 92.7 | 97.5 | 65.2 | 162.7 | 90.0 |
| Tax % | 18.8% | 25% | 28.1% | 32% | 22% | 24.7% | 18.8% | 29% | 26.9% | 20% |
| Net Profit | 70.7 | 51.8 | 40.7 | 30.7 | 109.8 | 69.8 | 79.2 | 46.3 | 119.0 | 72.0 |
| EPS in Rs | 4 | 3 | 2 | 1 | 6 | 4 | 4 | 2 | 7 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 11% |
| 3 Years: | 2% |
| TTM: | -8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 10% |
| 3 Years: | 13% |
| 1 Year: | -12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 11% |
| 3 Years: | 1% |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 10% |
| 3 Years: | 13% |
| 1 Year: | -12% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|